User:Schoenhg/sandbox
Appearance
References
[edit]- ^ a b Dawson, Marcia I.; Xia, Zebin (2012). "The retinoid X receptors and their ligands". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1821: 21–56. doi:10.1016/j.bbalip.2011.09.014. PMC 4097889. PMID 22020178.
{{cite journal}}
: CS1 maint: date and year (link) - ^ a b Lippman, Scott M. (2000). "Advances in the Development of Retinoids as Chemopreventive Agents". The Journal of Nutrition. 130 (2S Suppl): 479–482. doi:10.1093/jn/130.2.479S. PMID 10721933.
{{cite journal}}
: Unknown parameter|coauthors=
ignored (|author=
suggested) (help) - ^ a b Pérez, Efrén; Bourguet, William; Gronemeyer, Hinrich; De Lera, Angel R. (2012). "Modulation of RXR function through ligand design". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1821: 57–69. doi:10.1016/j.bbalip.2011.04.003. PMID 21515403.
{{cite journal}}
: CS1 maint: date and year (link) - ^ a b Howe, Louise R. (2007). "Rexinoids and Breast Cancer Prevention". Clin Cancer Res. 13 (20): 5983–5987. doi:10.1158/1078-0432.CCR-07-1065. PMID 17947457. S2CID 34679944.
- ^ a b Vaz, Belén; r De Lera, Ángel (2012). "Advances in drug design with RXR modulators". Expert Opin. Drug Discov. 7 (11): 1003–1016. doi:10.1517/17460441.2012.722992. PMID 22954251. S2CID 36317393.
{{cite journal}}
: CS1 maint: date and year (link) - ^ a b Smith, Wade; Saba, Nabil (2005). "Retinoids as chemoprevention for head and neck cancer: where do we go from here?". Critical Reviews in Oncology/Hematology. 55 (2): 143–152. doi:10.1016/j.critrevonc.2005.02.003. PMID 15886010.
{{cite journal}}
: CS1 maint: date and year (link) - ^ a b Tanaka, Takemi; De Luca, Luigi M. (2009). "Therapeutic Potential of Rexinoids in Cancer Prevention and Treatment". Cancer Res. 69 (12): 4945–4947. doi:10.1158/0008-5472.CAN-08-4407. PMID 19509234. S2CID 6167750.
{{cite journal}}
: CS1 maint: date and year (link)